Real-world one year outcomes of a switch to aflibercept from ranibizumab in neovascular age related macular degeneration

被引：0
|
作者：
Citu, Maria Cristina [1 ,2 ]
Crosby-Nwaobi, Roxanne R. [1 ,2 ]
Eleftheriadou, Maria [1 ,2 ]
Vazquez-Alfageme, Clara [1 ,2 ]
Nicholson, Luke [1 ,2 ]
Sivaprasad, Sobha [1 ,2 ]
Hykin, Philip [1 ,2 ]
Hamilton, Robin D. [1 ,2 ]
机构：
[1] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England
[2] UCL, Inst Ophthalmol, London, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3342
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Comparison of intravitreal injections of Ranibizumab and Aflibercept in neovascular age related macular degeneration
    Sizmaz, Selcuk
    Esen, Ebru
    Isik-Ericek, Puren
    Demircan, Nihal
    [J]. CLINICAL AND EXPERIMENTAL OPTOMETRY, 2022, 105 (01) : 55 - 60
  • [32] Outcomes at 1 Year with Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration: Real-World Results from the LUMINOUS Study
    Mitchell, Paul
    Macfadden, Wayne
    Lacey, Sue
    [J]. OPHTHALMOLOGICA, 2016, 236 : 1 - 1
  • [33] Short-Term Real-World Outcomes of Intensive Aflibercept Injection for Refractory Neovascular Age-Related Macular Degeneration
    Son, Wonyung
    Sagong, Min
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (12)
  • [34] Switching Therapy from Ranibizumab and/or Bevacizumab to Aflibercept in Neovascular Age-Related Macular Degeneration (AMD): One-Year Results
    Pfau, M.
    Fassnacht-Riederle, H. M.
    Freiberg, F. J.
    Wons, J. B.
    Wirth, M.
    Becker, M. D.
    Michels, S.
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2016, 233 (08) : 945 - 950
  • [35] Impact of injection frequency on 5-year real-world visual acuity outcomes of aflibercept therapy for neovascular age-related macular degeneration
    Chandra, Shruti
    Rasheed, Rajna
    Menon, Deepthy
    Patrao, Namritha
    Lamin, Ali
    Gurudas, Sarega
    Balaskas, Konstantinos
    Pater, Praveen J.
    Ali, Naser
    Sivaprasad, Sobha
    [J]. EYE, 2021, 35 (02) : 409 - 417
  • [36] Impact of injection frequency on 5-year real-world visual acuity outcomes of aflibercept therapy for neovascular age-related macular degeneration
    Shruti Chandra
    Rajna Rasheed
    Deepthy Menon
    Namritha Patrao
    Ali Lamin
    Sarega Gurudas
    Konstantinos Balaskas
    Praveen J. Patel
    Naser Ali
    Sobha Sivaprasad
    [J]. Eye, 2021, 35 : 409 - 417
  • [37] Ranibizumab treatment patterns in prior ranibizumab-treated neovascular age-related macular degeneration patients: Real-world outcomes from the LUMINOUS study
    Holz, Frank G.
    Minnella, Angelo M.
    Tuli, Raman
    Yoganathan, Pradeepa
    Parikh, Soumil
    Hamilton, Robin
    [J]. PLOS ONE, 2020, 15 (12):
  • [38] RANIBIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN A REAL WORLD CLINICAL SETTING
    Abell, Robin
    Lim, Diane
    Kerr, Nathan
    Allen, Penelope
    Vote, Brendan
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 40 : 103 - 104
  • [39] Six-year outcomes in neovascular age-related macular degeneration with ranibizumab
    Jacob, Julie
    Brie, Heidi
    Leys, Anita
    Levecq, Laurent
    Mergaerts, Filip
    Denhaerynck, Kris
    Vancayzeele, Stefaan
    Van Craeyveld, Eline
    Abraham, Ivo
    MacDonald, Karen
    [J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2017, 10 (01) : 81 - 90
  • [40] Predicting visual outcomes in patients treated with aflibercept for neovascular age-related macular degeneration: Data from a real-world clinical setting
    Fulcher, Corinne
    Hazel, Charlotte A.
    Pacey, Ian
    Ali, Hasan
    Ghanchi, Faruque D.
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (03) : 543 - 549
12345